Abstract
The notion that medicines derived from plants depend for their action on active principles present has to be modified in view of the findings that there are, in many cases, adjuvant substances in the plant which enhance the activity of the components actually responsible for the effect. This synergy may involve protection of an active substance from degradation by enzymes, it may facilitate transport across barriers such as cell and organelle walls, it may overcome multi-drug resistance mechanisms or provide other signals to the hosts cells that result in higher efficacy of the crude drug when compared with isolated components. The many plant substances that stimulate the immune system, often at very low doses, have not been reviewed as this is not strictly speaking synergy. Some of the evidence for the phenomena described is reviewed and its bearing on phytotherapy commented.
Keywords: Plant Medicines, multi-drug resistance, phytotherapy
Current Medicinal Chemistry
Title: Synergy in Plant Medicines
Volume: 10 Issue: 1
Author(s): Benjamin Gilbert and Lucio Ferreira Alves
Affiliation:
Keywords: Plant Medicines, multi-drug resistance, phytotherapy
Abstract: The notion that medicines derived from plants depend for their action on active principles present has to be modified in view of the findings that there are, in many cases, adjuvant substances in the plant which enhance the activity of the components actually responsible for the effect. This synergy may involve protection of an active substance from degradation by enzymes, it may facilitate transport across barriers such as cell and organelle walls, it may overcome multi-drug resistance mechanisms or provide other signals to the hosts cells that result in higher efficacy of the crude drug when compared with isolated components. The many plant substances that stimulate the immune system, often at very low doses, have not been reviewed as this is not strictly speaking synergy. Some of the evidence for the phenomena described is reviewed and its bearing on phytotherapy commented.
Export Options
About this article
Cite this article as:
Gilbert Benjamin and Alves Ferreira Lucio, Synergy in Plant Medicines, Current Medicinal Chemistry 2003; 10(1) . https://dx.doi.org/10.2174/0929867033368583
DOI https://dx.doi.org/10.2174/0929867033368583 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Use of Intracoronary Gene Transfer of Fibroblast Growth Factor for Coronary Artery Disease
Current Gene Therapy Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Biochemical Strategies to Anticoagulation: A Comparative Overview
Current Vascular Pharmacology Antimicrobial and Biofilm Inhibiting Diketopiperazines
Current Medicinal Chemistry Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
Current Medicinal Chemistry Anti-inflammatory Activity of Extra Virgin Olive Oil Polyphenols: Which Role in the Prevention and Treatment of Immune-Mediated Inflammatory Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Mean Platelet Volume and Platelet Distribution Width Correlate with Microvascular Complications in Egyptian People with Type 2 Diabetes Mellitus
Current Diabetes Reviews Vitamins in the Prevention or Delay of Cognitive Disability of Aging
Current Aging Science The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets Revisiting the J-curve Phenomenon. An Old New Concept?
Current Hypertension Reviews Editorial [Hot topic: Selected New Developments in Oncology (Guest Editors: Jos H. Beijnen and Jan H.M. Schellens)]
Current Clinical Pharmacology Hetero-Oligomerization of Chemokine Receptors: Diversity and Relevance for Function
Current Medicinal Chemistry Role of Free Radicals in Sepsis: Antioxidant Therapy
Current Pharmaceutical Design Design and Synthesis of Novel Spiro-Piperidinyl Pyrazolone Derivatives and Their Potential Antiviral Activity
Letters in Drug Design & Discovery Targeted Drug Delivery and Imaging Using Mobile Milli/Microrobots: A Promising Future Towards Theranostic Pharmaceutical Design
Current Pharmaceutical Design Benzodiazepines, Amphetamines, Testosterone, and Sildenafil as New Candidate Drugs for Sexual Interest, Desire and/or Arousal Disorder
Current Psychopharmacology The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review
Current HIV Research Evaluation of Anti-aging Compounds Using the Promoters of Elastin and Fibrillin-1 Genes Combined with a Secreted Alkaline Phosphatase Reporter in Normal Human Fibroblasts
Current Pharmaceutical Biotechnology